KYOWA KIRIN CO., LTD.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Public, Subsidiary
- Established
- 1949-07-01
- Employees
- 5.9K
- Market Cap
- -
- Website
- http://www.kyowa-kirin.co.jp
Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients
- First Posted Date
- 2019-03-06
- Last Posted Date
- 2024-03-07
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 47
- Registration Number
- NCT03864445
- Locations
- 🇯🇵
Study Site 1, Chiba, Japan
Dose-finding Study of KHK7791 in Hyperphosphatemia Patients
- First Posted Date
- 2019-03-06
- Last Posted Date
- 2024-03-07
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 207
- Registration Number
- NCT03864458
- Locations
- 🇯🇵
Study Site 1, Nagoya, Japan
Study of KHK 4323 in Healthy Volunteers and Subjects With Atopic Dermatitis
Phase 1
Terminated
- Conditions
- Interventions
- First Posted Date
- 2019-02-19
- Last Posted Date
- 2020-01-28
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 5
- Registration Number
- NCT03846466
- Locations
- 🇯🇵
Osaka Pharmacology Clinical research Hospital, Osaka, Japan
A Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on HD
- First Posted Date
- 2019-02-06
- Last Posted Date
- 2024-03-07
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 67
- Registration Number
- NCT03831607
- Locations
- 🇯🇵
Study Site 1, Niigata, Japan
A Study of Single and Multiple Doses of KW-6356 in Healthy Subjects
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2019-02-05
- Last Posted Date
- 2019-11-29
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT03830528
- Locations
- 🇯🇵
Medical Co. LTA Sumida Hospital, Tokyo, Japan
Study of KHK7580 in Subjects With Secondary Hyperparathyroidism in Asia
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2019-01-30
- Last Posted Date
- 2022-04-25
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 404
- Registration Number
- NCT03822507
- Locations
- 🇨🇳
Research site_3, Kaohsiung, Taiwan
🇨🇳Research site_5, Kaohsiung, Taiwan
🇨🇳Research site_6, Taipei, Taiwan
Study of Longitudinal Observation for Patient With X-linked Hypophosphatemic Rickets/Osteomalacia in Collaboration With Asian Partners
- First Posted Date
- 2018-11-19
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 226
- Registration Number
- NCT03745521
- Locations
- 🇯🇵
Osaka University Hospital, Osaka, Japan
A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations
- First Posted Date
- 2018-10-12
- Last Posted Date
- 2020-09-07
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 502
- Registration Number
- NCT03703570
- Locations
- 🇯🇵
Iwamizawa Neurology Clinic, Iwamizawa, Hokkaido, Japan
A Phase 3 Study of Bardoxolone Methyl in Patients With Diabetic Kidney Disease; AYAME Study
Phase 3
Terminated
- Conditions
- Interventions
- First Posted Date
- 2018-06-08
- Last Posted Date
- 2023-09-26
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 1323
- Registration Number
- NCT03550443
- Locations
- 🇯🇵
Japan Community Health care Organization Sendai Hospital, Sendai, Miyagi, Japan
Phase 2 Study of KHK2375 in Subjects With Advanced or Recurrent Breast Cancer
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-09-25
- Last Posted Date
- 2022-06-21
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 133
- Registration Number
- NCT03291886
- Locations
- 🇯🇵
Tsukuba University Hospital, Tsukuba, Ibaraki, Japan
🇯🇵National Cancer Center Hospital, Chuo, Tokyo, Japan
🇯🇵Toranomon Hospital, Minato, Tokyo, Japan
© Copyright 2024. All Rights Reserved by MedPath